1. Home
  2. LIXT vs AMIX Comparison

LIXT vs AMIX Comparison

Compare LIXT & AMIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LIXT
  • AMIX
  • Stock Information
  • Founded
  • LIXT 2005
  • AMIX 2014
  • Country
  • LIXT United States
  • AMIX United States
  • Employees
  • LIXT N/A
  • AMIX N/A
  • Industry
  • LIXT Biotechnology: Pharmaceutical Preparations
  • AMIX
  • Sector
  • LIXT Health Care
  • AMIX
  • Exchange
  • LIXT Nasdaq
  • AMIX NYSE
  • Market Cap
  • LIXT 3.0M
  • AMIX 3.5M
  • IPO Year
  • LIXT N/A
  • AMIX N/A
  • Fundamental
  • Price
  • LIXT $0.74
  • AMIX $1.25
  • Analyst Decision
  • LIXT
  • AMIX Strong Buy
  • Analyst Count
  • LIXT 0
  • AMIX 1
  • Target Price
  • LIXT N/A
  • AMIX $5.00
  • AVG Volume (30 Days)
  • LIXT 82.2K
  • AMIX 2.5M
  • Earning Date
  • LIXT 08-07-2025
  • AMIX 08-12-2025
  • Dividend Yield
  • LIXT N/A
  • AMIX N/A
  • EPS Growth
  • LIXT N/A
  • AMIX N/A
  • EPS
  • LIXT N/A
  • AMIX N/A
  • Revenue
  • LIXT N/A
  • AMIX N/A
  • Revenue This Year
  • LIXT N/A
  • AMIX N/A
  • Revenue Next Year
  • LIXT N/A
  • AMIX N/A
  • P/E Ratio
  • LIXT N/A
  • AMIX N/A
  • Revenue Growth
  • LIXT N/A
  • AMIX N/A
  • 52 Week Low
  • LIXT $0.64
  • AMIX $1.14
  • 52 Week High
  • LIXT $3.00
  • AMIX $42.40
  • Technical
  • Relative Strength Index (RSI)
  • LIXT 30.79
  • AMIX 35.38
  • Support Level
  • LIXT $0.64
  • AMIX $1.14
  • Resistance Level
  • LIXT $0.93
  • AMIX $1.36
  • Average True Range (ATR)
  • LIXT 0.13
  • AMIX 0.10
  • MACD
  • LIXT -0.05
  • AMIX 0.00
  • Stochastic Oscillator
  • LIXT 16.99
  • AMIX 26.83

About LIXT Lixte Biotechnology Holdings Inc.

Lixte Biotechnology Holdings Inc is a biopharmaceutical company dedicated to improving patients' lives by developing a drug class called Protein Phosphatase 2A inhibitors. Its product pipeline is focused on inhibitors of protein phosphatase 2A, used in combination with cytotoxic agents and/or x-rays, immune checkpoint blockers, and other cancer therapies. The Company believes that inhibitors of protein phosphatases have therapeutic potential for a broad range of cancers. It focuses on the clinical development of a specific protein phosphatase inhibitor, referred to as LB-100, which has been shown to have clinical anti-cancer activity at doses that produce little or no toxicity.

About AMIX AUTONOMIX MEDICAL INC

Autonomix Medical Inc is a development-stage medical device development company focused on advancing technologies for sensing and treating disorders relating to the nervous system. Its first-in-class technology platform includes a catheter-based microchip-enabled array that can detect and differentiate neural signals with a high degree of sensitivity as demonstrated in animal studies.

Share on Social Networks: